Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response and Survival in Patients With Esophageal Cancer

作者: Priya Jayachandran , Reetesh K. Pai , Andrew Quon , Edward Graves , Trevor E. Krakow

DOI: 10.1016/J.IJROBP.2011.12.029

关键词: Esophageal cancerRetrospective cohort studyNuclear medicineAdenocarcinomaPositron emission tomographyChemoradiotherapyTumor Regression GradeMedicineStandardized uptake valueRadiologyStage (cooking)

摘要: Purpose To correlate the prechemoradiotherapy (CRT) and post-CRT metabolic tumor volume (MTV) on positron emission tomography (PET) scanning with pathologic response survival in patients receiving preoperative CRT for esophageal cancer. Materials Methods The medical records of 37 histologically confirmed Stage I–IVA cancer treated or without surgical resection were reviewed. Of patients, 21 received (57%) 16 definitive (43%). All had a pre-CRT 32 PET scan. MTV was measured scan, respectively, using minimum standardized uptake value (SUV) threshold x, where x=2, 2.5, 3, SUV maximum × 50%. total glycolytic activity (TGA x ) defined as mean . ratio MTV/post-CRT MTV. similarly. A single pathologist scored regression grade (TRG) scale. Results median follow-up 1.5 years (range, 0.4–4.9). No significant correlation found between any parameters scan TRG overall (OS). Multiple values post-TGA correlated OS; however, 2.5Post TGA greatest correlation. 2 OS. either scans did not Patients preoperatively similar compared those definitively good ( p = 0.97) significantly better than that poor Conclusion predictive prognostic parameter. 2.5 useful markers predicting also survival. Post-CRT can potentially guide therapy after CRT.

参考文章(28)
Johannes B. Roedl, Rivka R. Colen, Nagaraj S. Holalkere, Alan J. Fischman, Noah C. Choi, Michael A. Blake, Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET–CT: Comparison to histopathologic and clinical response evaluation Radiotherapy and Oncology. ,vol. 89, pp. 278- 286 ,(2008) , 10.1016/J.RADONC.2008.06.014
Wolfgang A. Weber, Katja Ott, Karen Becker, Hans-Joachim Dittler, Hermann Helmberger, Norbert E. Avril, Günther Meisetschläger, Raymonde Busch, Jörg-Rüdiger Siewert, Markus Schwaiger, Ulrich Fink, Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging Journal of Clinical Oncology. ,vol. 19, pp. 3058- 3065 ,(2001) , 10.1200/JCO.2001.19.12.3058
John F. Bruzzi, Stephen G. Swisher, Mylene T. Truong, Reginald F. Munden, Wayne L. Hofstetter, Homer A. Macapinlac, Arlene M. Correa, Osama Mawlawi, Jaffer A. Ajani, Ritsuko R. Komaki, Norio Fukami, Jeremy J. Erasmus, Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer. ,vol. 109, pp. 125- 134 ,(2007) , 10.1002/CNCR.22397
Edward A. Levine, Michael R. Farmer, Paige Clark, Girish Mishra, Coty Ho, Kim R. Geisinger, Susan A. Melin, James Lovato, Tim Oaks, A William Blackstock, Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Annals of Surgery. ,vol. 243, pp. 472- 478 ,(2006) , 10.1097/01.SLA.0000208430.07050.61
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Percy Lee, Jose G. Bazan, Philip W. Lavori, Dilani K. Weerasuriya, Andrew Quon, Quynh-Thu Le, Heather A. Wakelee, Edward E. Graves, Billy W. Loo, Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer Clinical Lung Cancer. ,vol. 13, pp. 52- 58 ,(2012) , 10.1016/J.CLLC.2011.05.001
Florian Lordick, Katja Ott, Bernd-Joachim Krause, Wolfgang A Weber, Karen Becker, Hubert J Stein, Sylvie Lorenzen, Tibor Schuster, Hinrich Wieder, Ken Herrmann, Rainer Bredenkamp, Heinz Höfler, Ulrich Fink, Christian Peschel, Markus Schwaiger, Jörg R Siewert, PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncology. ,vol. 8, pp. 797- 805 ,(2007) , 10.1016/S1470-2045(07)70244-9
Richard V. Scheer, Achilles J. Fakiris, Peter A.S. Johnstone, Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer. International Journal of Radiation Oncology Biology Physics. ,vol. 80, pp. 996- 1001 ,(2011) , 10.1016/J.IJROBP.2010.03.003
James D. Murphy, Trang H. La, Karen Chu, Andrew Quon, Nancy J. Fischbein, Peter G. Maxim, Edward E. Graves, Billy W. Loo, Quynh-Thu Le, Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer. International Journal of Radiation Oncology Biology Physics. ,vol. 80, pp. 514- 521 ,(2011) , 10.1016/J.IJROBP.2010.01.057
Stephen G. Swisher, Jeremy Erasmus, Mary Maish, Arlene M. Correa, Homer Macapinlac, Jaffer A. Ajani, James D. Cox, Ritsuko R. Komaki, David Hong, Hoon K. Lee, Joe B. Putnam, David C. Rice, W. Roy Smythe, Linh Thai, Ara A. Vaporciyan, Garrett L. Walsh, Tsung-Teh Wu, Jack A. Roth, 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer. ,vol. 101, pp. 1776- 1785 ,(2004) , 10.1002/CNCR.20585